超90亿元!济川药业80后“实控人儿子”拟全面要约收购上市公司

中新经纬
Jun 16, 2025

15日晚间,湖北济川药业股份有限公司(下称济川药业)发布公告,披露公司收到要约收购报告书及实控人家族内部股权结构调整。公告显示,11日,济川药业实际控制人曹龙祥与其子曹飞签署《江苏济川控股集团有限公司股权转让协议》,曹龙祥拟将其所持江苏济川控股集团有限公司(下称济川控股)10.10%的股权以1010万元价格转让给曹飞。本次股权转让完成后,曹飞持有济川控股60%的股权,成为济川控股的控股股东,并通过...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10